Terms: = Germ cell tumor AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Treatment
811 results:
1. Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness.
Mongiardi MP; Pallini R; D'Alessandris QG; Levi A; Falchetti ML
Expert Rev Mol Med; 2024 Apr; 26():e5. PubMed ID: 38563164
[TBL] [Abstract] [Full Text] [Related]
2. IL-12-Overexpressed Nanoparticles Suppress the Proliferation of Melanoma Through Inducing ICD and Activating DC, CD8
Shen HH; Peng JF; Wang RR; Wang PY; Zhang JX; Sun HF; Liang Y; Li YM; Xue JN; Li YJ; Sun GB; Xie SY
Int J Nanomedicine; 2024; 19():2755-2772. PubMed ID: 38525008
[TBL] [Abstract] [Full Text] [Related]
3. Molecular Frontiers in Melanoma: Pathogenesis, Diagnosis, and Therapeutic Advances.
Kim HJ; Kim YH
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474231
[TBL] [Abstract] [Full Text] [Related]
4. Nilotinib in kit-driven advanced melanoma: Results from the phase II single-arm NICAM trial.
Larkin J; Marais R; Porta N; Gonzalez de Castro D; Parsons L; Messiou C; Stamp G; Thompson L; Edmonds K; Sarker S; Banerji J; Lorigan P; Evans TRJ; Corrie P; Marshall E; Middleton MR; Nathan P; Nicholson S; Ottensmeier C; Plummer R; Bliss J; Valpione S; Turajlic S
Cell Rep Med; 2024 Mar; 5(3):101435. PubMed ID: 38417447
[TBL] [Abstract] [Full Text] [Related]
5. Genistin Represses the Proliferation and Angiogenesis While Accelerating the Apoptosis of Glioma cells by Modulating the FOXC1-Mediated Wnt Signaling Pathway.
Lan X; Gui Z; Chen T; Tang M; Wang H
Discov Med; 2024 Feb; 36(181):332-342. PubMed ID: 38409838
[TBL] [Abstract] [Full Text] [Related]
6. FTO promotes the progression of retinoblastoma through YTHDF2-dependent N6-methyladenosine modification in E2F3.
Xie W; Shao Y; Bo Q; Li Z; Yu Q; Wang L; Wu G
Mol Carcinog; 2024 May; 63(5):926-937. PubMed ID: 38380957
[TBL] [Abstract] [Full Text] [Related]
7. Mechanistic study of the anti-excitatory amino acid toxicity of Bushen Zhichan decoction for Parkinson's disease based on the transcriptional regulation of EAAT1 by YY1.
Liu L; Tian X; Li W
J Ethnopharmacol; 2024 May; 325():117857. PubMed ID: 38350506
[TBL] [Abstract] [Full Text] [Related]
8. Exploration of genetic characterization in hyperprogressive disease after immunotherapy retreatment in a patient with LCNEC: A case report.
Zhang Y; Yang J; Shao T; Chen J; Shu Q; Shou L
Hum Vaccin Immunother; 2024 Dec; 20(1):2313281. PubMed ID: 38348622
[TBL] [Abstract] [Full Text] [Related]
9. FOXM1 promote the growth and metastasis of uveal melanoma cells by regulating CDK2 expression.
Bai X; Li S; Luo Y
Int Ophthalmol; 2024 Feb; 44(1):55. PubMed ID: 38342795
[TBL] [Abstract] [Full Text] [Related]
10. Evodiamine inhibits growth of vemurafenib drug-resistant melanoma via suppressing IRS4/PI3K/AKT signaling pathway.
Guo X; Huang S; Zhang Y; Wang H; Li L; Ran J; Chen D; Li X; Li J
J Nat Med; 2024 Mar; 78(2):342-354. PubMed ID: 38324123
[TBL] [Abstract] [Full Text] [Related]
11. Etomidate inhibits tumor growth of glioblastoma by regulating M1 macrophage polarization.
Gao C; Nie Y
Metab Brain Dis; 2024 Apr; 39(4):569-576. PubMed ID: 38300392
[TBL] [Abstract] [Full Text] [Related]
12. The promotive role of lncRNA MIR205HG in proliferation, invasion, and migration of melanoma cells via the JMJD2C/ALKBH5 axis.
Liu Y; Wang S; Wei S; Qiu X; Mei Y; Yan L
PLoS One; 2024; 19(1):e0290986. PubMed ID: 38252669
[TBL] [Abstract] [Full Text] [Related]
13. Anlotinib alone or in combination with bevacizumab in the treatment of recurrent high-grade glioma: a prospective single-arm, open-label phase II trial.
Zhao S; Zhang M; Zhang Q; Wu J; Dai H
BMC Cancer; 2024 Jan; 24(1):6. PubMed ID: 38166698
[TBL] [Abstract] [Full Text] [Related]
14. Factors Affecting Recurrence and Survival for Patients with High-Risk Stage II Melanoma.
Dedeilia A; Lwin T; Li S; Tarantino G; Tunsiricharoengul S; Lawless A; Sharova T; Liu D; Boland GM; Cohen S
Ann Surg Oncol; 2024 Apr; 31(4):2713-2726. PubMed ID: 38158497
[TBL] [Abstract] [Full Text] [Related]
15. Comprehensive molecular findings in primary malignant melanoma of the esophagus: A multicenter study.
Deng L; Wang HY; Hu CF; Liu XY; Jiang K; Yong JJ; Wu XY; Guo KH; Wang F
Pigment Cell Melanoma Res; 2024 May; 37(3):363-371. PubMed ID: 38158377
[TBL] [Abstract] [Full Text] [Related]
16. REC8 regulates neuroblastoma cell proliferation, migration, invasion, and angiogenesis via STAT3/VEGF signaling.
Wang Q; Fan W; Hao Z; Liang B; Fan M; Zhao Z; Li Z
J Egypt Natl Canc Inst; 2023 Dec; 35(1):41. PubMed ID: 38105365
[TBL] [Abstract] [Full Text] [Related]
17. STING promotes invasion and migration of uveal melanoma through p38‑MAPK signaling.
Zhou X; Meng F; Xu B; Ma R; Cheng Y; Wu J; Qian J
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38099424
[TBL] [Abstract] [Full Text] [Related]
18. The Effect of
Ma C; Gao Q; Zhang L; Li C; Wu G; Yang L
Discov Med; 2023 Dec; 35(179):1123-1133. PubMed ID: 38058078
[TBL] [Abstract] [Full Text] [Related]
19. treatment of acral and mucosal melanoma: Current and emerging targeted therapies.
Zhang J; Tian H; Mao L; Si L
Crit Rev Oncol Hematol; 2024 Jan; 193():104221. PubMed ID: 38036156
[TBL] [Abstract] [Full Text] [Related]
20. [Efficacy of adjuvant programmed cell death 1 (PD-1) monoclonal antibody immunotherapy in Chinese patients with resected stage Ⅱ-Ⅲ melanoma].
Ren ZG; Xu Y; Hua ZZ; Mo ZY; Wang LW; Shi GB; Liu WL; Sun W; Zheng BQ; Wang CM; Jin YJ; Chen Y
Zhonghua Zhong Liu Za Zhi; 2023 Nov; 45(11):973-980. PubMed ID: 37968084
[No Abstract] [Full Text] [Related]
[Next]
